Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery - Wikidata - awgldk - TriplyDB

Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery

Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery

http://www.wikidata.org/entity/Q35238275

about

Lipid-based vectors for siRNA delivery Combinatorial library of lipidoids for in vitro DNA delivery.Rational design of a biomimetic cell penetrating peptide library.A plug-and-play ratiometric pH-sensing nanoprobe for high-throughput investigation of endosomal escape.Combinatorial library strategies for synthesis of cationic lipid-like nanoparticles and their potential medical applications.Combinatorial Approach to Nanoarchitectonics for Nonviral Delivery of Nucleic Acids.In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery.ENDOCYTOSIS PATHWAYS FOR NUCLEIC ACID THERAPEUTICS.Design of siRNA Therapeutics from the Molecular Scale Liposome-like Nanostructures for Drug Delivery.Lipid-modified aminoglycoside derivatives for in vivo siRNA delivery.Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis.Therapeutic siRNA: principles, challenges, and strategies.Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC.Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs.Cationic α-cyclodextrin:poly(ethylene glycol) polyrotaxanes for siRNA delivery.Multi-armed cationic cyclodextrin:poly(ethylene glycol) polyrotaxanes as efficient gene silencing vectors.A window onto siRNA delivery.Acidic pH-responsive siRNA conjugate for reversible carrier stability and accelerated endosomal escape with reduced IFNα-associated immune response.Transfection by cationic gemini lipids and surfactants A novel Lipidoid-MicroRNA formulation promotes calvarial bone regeneration

P2860

Q28828356-B421C325-298A-4A6F-9985-FD90BB03DE83 Q34093400-DA64D2F8-BE2D-4F7A-B15A-F4281F12089C Q34991955-151CDB5D-D1B0-46C1-B57B-996EB93A7F2C Q35295342-310243DD-E37E-413D-AC0A-39C054BF589C Q35568750-712B7857-741D-4692-B6F1-6F2E55703DDF Q35853451-661C8C1D-08A6-455F-B93D-AAA96BC56CBA Q36195057-A9F62338-E405-4289-A551-C5BDBEC7FDB2 Q37094403-1D5E86DC-1E44-45DA-AC42-3D46AACD5251 Q37111734-F8E79B94-60B5-452C-AD5B-3BA30411E7ED Q37424654-9CA44522-F340-46AD-8773-F3F59DFD4CFD Q37503581-45903BD6-415B-44C8-8DEE-D3AF1B4D42E8 Q37577606-68D18C0B-EF4F-4769-ABF3-765D34FF47C0 Q37636279-234B739F-D80B-4A1C-B215-24CB589A5ED5 Q38021996-D7B49A7D-C24E-40B4-BAF3-25F82BBDF8C1 Q38692510-B9AD3941-F4C9-42E4-8FA7-1503929CE164 Q39003380-965E9BD4-A950-463F-AF6D-356B3BA663F3 Q41813002-3BEC29AE-2DB0-4247-87D9-C329ECF3D5F7 Q42031723-10A9AB32-47CD-4CEA-BBC5-F2B29BDAA554 Q46010754-42879D0F-CA7E-46DB-850A-8831AD53AC94 Q46543595-8B97D3E4-6ACA-472F-A709-79A7FC7010BE Q57139324-3A42AC0E-B137-4A67-9A03-828D43FA34B2 Q57214413-23FDC775-FF8A-40C5-A6A4-634CBFC48F0D

P2860

Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery

http://www.wikidata.org/entity/Q35238275

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Synergistic silencing: combina ...... for efficacious siRNA delivery

@ast

Synergistic silencing: combina ...... for efficacious siRNA delivery

@en

type

label

Synergistic silencing: combina ...... for efficacious siRNA delivery

@ast

Synergistic silencing: combina ...... for efficacious siRNA delivery

@en

prefLabel

Synergistic silencing: combina ...... for efficacious siRNA delivery

@ast

Synergistic silencing: combina ...... for efficacious siRNA delivery

@en

P1433

Q35238275-F2CC1C29-1ECA-4185-B5E4-CDF991406D96

P1476

Q35238275-CFE5261B-0268-4E74-8CED-222374A5E696

P2093

Q35238275-0998EF2F-DD2F-4F58-9906-48D070D05BAA

Q35238275-0C38DB56-B6AD-49A7-BAA2-D29938B9D324

Q35238275-28D9848F-0E40-44B7-88E9-B20EA6C04EF0

Q35238275-601B176A-3401-4A4E-8CDE-237F192877CC

Q35238275-7DC77676-7C87-4124-A268-4C29D0BF92B3

Q35238275-9D2F3915-A4F1-4555-AE31-237E6451704E

Q35238275-A1CE1032-91F3-4F12-A91F-D6E507448D23

Q35238275-B49B9E9D-11B3-43A8-A201-E3FA5C9F5FEF

Q35238275-D3E63EBA-F1B4-47BE-B4F8-2A72321FD8AC

Q35238275-DC600D75-917A-42AC-AC07-B8B28843382C

P2860

Q35238275-154B802C-577F-4483-89A2-3AE82E996C5B

Q35238275-26C877B8-3091-4740-BB09-B76F413256CE

Q35238275-2BE85B68-B03D-4987-979F-08996580E09D

Q35238275-2C5C432A-E623-40B4-AB30-48939C353661

Q35238275-35227312-8C76-467C-8BDA-94E7F0A4E200

Q35238275-4D9C9B92-7AE2-4CE0-8E91-55BD37F8C628

Q35238275-698803B1-7A31-428D-AACC-586FEBB4DE7C

Q35238275-6D3C5E16-0CE0-45E1-8865-FD7434CA2C89

Q35238275-76B80CF2-A606-45F8-9C40-8591C7C0581E

Q35238275-7CE63051-CD8A-4D72-9B4F-79D1C1ED315C

P304

Q35238275-A132D1B1-2E36-4154-BAC8-1A575DCEFACC

P31

Q35238275-176C0DDE-AD9A-440F-B063-04164F279C53

P356

Q35238275-666F7C63-8A72-48BD-8CAC-78A975024E00

P433

Q35238275-551830FA-D75A-4F1F-8CB7-2C60C0392D72

P478

Q35238275-B98D799A-E3D4-490E-8D8F-A0D741D5AA3B

P577

Q35238275-EE06C9CE-3D2C-4369-8F43-62BCF8B5A1BB

P5875

Q35238275-91BC38D4-0133-4397-9A58-C6D7D1091E24

P698

Q35238275-4EAFB6C2-7BBC-4CD1-A09D-2803513803AF

P932

Q35238275-E25C497C-73C4-478A-B735-077E82AD4366

P356

P1433

Molecular Therapy

P1476

Synergistic silencing: combina ...... for efficacious siRNA delivery

@en

P2093

Christopher A Alabi

http://www.w3.org/2001/XMLSchema#string

Christopher Zurenko

http://www.w3.org/2001/XMLSchema#string

Daniel G Anderson

http://www.w3.org/2001/XMLSchema#string

Gaurav Sahay

http://www.w3.org/2001/XMLSchema#string

George Z Li

http://www.w3.org/2001/XMLSchema#string

Kathryn A Whitehead

http://www.w3.org/2001/XMLSchema#string

Kevin T Love

http://www.w3.org/2001/XMLSchema#string

Minglin Ma

http://www.w3.org/2001/XMLSchema#string

Robert S Langer

http://www.w3.org/2001/XMLSchema#string

William Querbes

http://www.w3.org/2001/XMLSchema#string

P2860

ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.

Lipid-like materials for low-dose, in vivo gene silencing

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

P304

1688-1694

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2011.141

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51487003

http://www.w3.org/2001/XMLSchema#string

P698

21750531

http://www.w3.org/2001/XMLSchema#string

P932

3182356

http://www.w3.org/2001/XMLSchema#string